{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-082245","form_type":"8-K","ticker":"FRMM","cik":"0001690080","company_name":"FORUM MARKETS Inc","filed_at":"2022-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.719358+00:00","generated_at":"2026-06-21T00:07:47.236649+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"180 Life Sciences raises ~$6M in registered direct offering of shares and warrants","bullets":["Gross proceeds ~$6M from 1,714,286 shares (or equivalents) and warrants for 2,571,429 shares at $3.50/unit.","Net proceeds ~$5.5M after fees; use includes R&D, marketing authorization for Dupuytren's contracture in UK.","Warrants exercisable at $3.50/share starting 6 months after issuance, expiring 5 years from exercise date.","Directors and executive officers subject to 90-day lock-up on company securities post-closing.","A.G.P./Alliance Global Partners acted as sole placement agent for the offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-082245","json":"https://secwatch.observer/filing/0001213900-22-082245.json","markdown":"https://secwatch.observer/filing/0001213900-22-082245.md","text":"https://secwatch.observer/filing/0001213900-22-082245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/0001213900-22-082245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/ea170740-8k_180lifesci.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T00:07:47.236649+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13512a0d12ca249b81c31f87d10da6459a57316b","claim":"FORUM MARKETS Inc entered into Purchase Agreement with a certain institutional investor valued at approximately $6 million (effective 2022-12-20).","evidence_excerpt":"On December 20, 2022, 180 Life Sciences Corp., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with a certain institutional investor (the “ Purchaser ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/0001213900-22-082245-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain institutional investor"},{"label":"Value","value":"approximately $6 million"},{"label":"Effective","value":"2022-12-20"}],"fact_type":"material_agreement"},{"claim_id":"d3434a5684555ad0d48041a53262c499576ac3c4","claim":"FORUM MARKETS Inc entered into Warrant Agent Agreement with Continental Stock Transfer & Trust Company (effective 2022-12-22).","evidence_excerpt":"On December 22, 2022, in connection with the closing of the offering, the Company entered into a Warrant Agent Agreement with Continental Stock Transfer & Trust Company, as warrant agent, in connection with each of the Pre-Funded Warrants and the Common Warrants (each, a “ Warrant Agent Agreement ” and, collectively, the “ Warrant Agent Agreements ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/0001213900-22-082245-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Continental Stock Transfer & Trust Company"},{"label":"Effective","value":"2022-12-22"}],"fact_type":"material_agreement"},{"claim_id":"e973cfdd70fed0949bd6aca8d5287487af78ad9c","claim":"FORUM MARKETS Inc entered into Placement Agent Agreement with A.G.P./Alliance Global Partners (effective 2022-12-20).","evidence_excerpt":"On December 20, 2022, the Company also entered into a placement agent agreement (the “ Placement Agent Agreement ”) with A.G.P./Alliance Global Partners (the “ Placement Agent ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/0001213900-22-082245-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners"},{"label":"Effective","value":"2022-12-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}